{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:09:56Z","timestamp":1795028996616,"version":"4.10.2"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Mater"],"DOI":"10.1038\/s41578-022-00458-5","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T07:06:28Z","timestamp":1658214388000},"page":"796-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Polymeric particle-based therapies for acute inflammatory diseases"],"prefix":"10.1038","volume":"7","author":[{"given":"Emma R.","family":"Brannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Valentina","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-2379","authenticated-orcid":false,"given":"Noah J.","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8728-6608","authenticated-orcid":false,"given":"Omolola","family":"Eniola-Adefeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"458_CR1","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nri2873","volume":"10","author":"GY Chen","year":"2010","unstructured":"Chen, G. Y. & Nu\u00f1ez, G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826\u2013837 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159\u2013175 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","volume":"15","author":"KC Navegantes","year":"2017","unstructured":"Navegantes, K. C. et al. Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity. J. Transl Med. 15, 36 (2017).","journal-title":"J. Transl Med."},{"key":"458_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8, S3 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"458_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2613.2006.00507.x","volume":"88","author":"T Lawrence","year":"2007","unstructured":"Lawrence, T. & Gilroy, D. W. Chronic inflammation: a failure of resolution? Int. J. Exp. Pathol. 88, 85\u201394 (2007).","journal-title":"Int. J. Exp. Pathol."},{"key":"458_CR6","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/pharmaceutics12121222","volume":"12","author":"Y Su","year":"2020","unstructured":"Su, Y., Gao, J., Kaur, P. & Wang, Z. Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases. Pharmaceutics 12, 1222 (2020).","journal-title":"Pharmaceutics"},{"key":"458_CR7","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.3389\/fimmu.2018.02379","volume":"9","author":"GP Amarante-Mendes","year":"2018","unstructured":"Amarante-Mendes, G. P. et al. Pattern recognition receptors and the host cell death molecular machinery. Front. Immunol. 9, 2379 (2018).","journal-title":"Front. Immunol."},{"key":"458_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen, T. H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22, 240\u2013273 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"458_CR9","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1172\/JCI61758","volume":"122","author":"EK Koltsova","year":"2012","unstructured":"Koltsova, E. K. et al. Dynamic T cell\u2013APC interactions sustain chronic inflammation in atherosclerosis. J. Clin. Invest. 122, 3114\u20133126 (2012).","journal-title":"J. Clin. Invest."},{"key":"458_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-3083.2009.02255.x","volume":"69","author":"A Castellheim","year":"2009","unstructured":"Castellheim, A., Brekke, O. L., Espevik, T., Harboe, M. & Mollnes, T. E. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol. 69, 479\u2013491 (2009).","journal-title":"Scand. J. Immunol."},{"key":"458_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/jpan.2003.50013","volume":"18","author":"B George-Gay","year":"2003","unstructured":"George-Gay, B. & Parker, K. Understanding the complete blood count with differential. J. Perianesth. Nurs. 18, 96\u2013117 (2003).","journal-title":"J. Perianesth. Nurs."},{"key":"458_CR12","doi-asserted-by":"publisher","first-page":"L200","DOI":"10.1152\/ajplung.00346.2005","volume":"291","author":"A Basit","year":"2006","unstructured":"Basit, A. et al. ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L200\u2013L207 (2006).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"458_CR13","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","volume":"10","author":"A Ivetic","year":"2019","unstructured":"Ivetic, A., Hoskins Green, H. L. & Hart, S. J. L-selectin: a major regulator of leukocyte adhesion, migration and signaling. Front. Immunol. 10, 1068 (2019).","journal-title":"Front. Immunol."},{"key":"458_CR14","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.4049\/jimmunol.165.5.2764","volume":"165","author":"KL Davenpeck","year":"2000","unstructured":"Davenpeck, K. L., Brummet, M. E., Hudson, S. A., Mayer, R. J. & Bochner, B. S. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. J. Immunol. 165, 2764 (2000).","journal-title":"J. Immunol."},{"key":"458_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0471-y","volume":"17","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. The regulatory roles of neutrophils in adaptive immunity. Cell Commun. Signal. 17, 147 (2019).","journal-title":"Cell Commun. Signal."},{"key":"458_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","volume":"53","author":"N Mangalmurti","year":"2020","unstructured":"Mangalmurti, N. & Hunter, C. A. Cytokine storms: understanding COVID-19. Immunity 53, 19\u201325 (2020).","journal-title":"Immunity"},{"key":"458_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","volume":"509","author":"P Song","year":"2020","unstructured":"Song, P., Li, W., Xie, J., Hou, Y. & You, C. Cytokine storm induced by SARS-CoV-2. Clin. Chim. Acta 509, 280\u2013287 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"458_CR19","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/cbin.11403","volume":"44","author":"N Fathi","year":"2020","unstructured":"Fathi, N. & Rezaei, N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol. Int. 44, 1792\u20131797 (2020).","journal-title":"Cell Biol. Int."},{"key":"458_CR20","first-page":"992","volume":"19","author":"A Nabil","year":"2020","unstructured":"Nabil, A. et al. Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: an updated review until June 2020. EXCLI J. 19, 992\u20131016 (2020).","journal-title":"EXCLI J."},{"key":"458_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(06)69005-3","volume":"368","author":"KA Brown","year":"2006","unstructured":"Brown, K. A. et al. Neutrophils in development of multiple organ failure in sepsis. Lancet 368, 157\u2013169 (2006).","journal-title":"Lancet"},{"key":"458_CR22","doi-asserted-by":"publisher","first-page":"e01753-18","DOI":"10.1128\/mBio.01753-18","volume":"9","author":"LE Gralinski","year":"2018","unstructured":"Gralinski, L. E. et al. Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9, e01753-18 (2018).","journal-title":"mBio"},{"key":"458_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molimm.2014.06.038","volume":"61","author":"J Szebeni","year":"2014","unstructured":"Szebeni, J. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol. Immunol. 61, 163\u2013173 (2014).","journal-title":"Mol. Immunol."},{"key":"458_CR24","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1021\/acsbiomaterials.0c00722","volume":"6","author":"N Maisha","year":"2020","unstructured":"Maisha, N., Coombs, T. & Lavik, E. Development of a sensitive assay to screen nanoparticles in vitro for complement activation. ACS Biomater. Sci. Eng. 6, 4903\u20134915 (2020).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"458_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","volume":"148","author":"PJ Barnes","year":"2006","unstructured":"Barnes, P. J. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br. J. Pharmacol. 148, 245\u2013254 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"458_CR26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li, P., Zheng, Y. & Chen, X. Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front. Pharmacol. 8, 460 (2017).","journal-title":"Front. Pharmacol."},{"key":"458_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1126\/science.1230720","volume":"339","author":"I Tabas","year":"2013","unstructured":"Tabas, I. & Glass, C. K. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339, 166\u2013172 (2013).","journal-title":"Science"},{"issue":"Suppl. 2","key":"458_CR28","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1007\/s000110050284","volume":"47","author":"JR Vane","year":"1998","unstructured":"Vane, J. R. & Botting, R. M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47 (Suppl. 2), S78\u2013S87 (1998).","journal-title":"Inflamm. Res."},{"key":"458_CR29","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/0016-5085(93)90667-2","volume":"104","author":"I Bjarnason","year":"1993","unstructured":"Bjarnason, I., Hayllar, J., MacPherson, A. J. & Russell, A. S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104, 1832\u20131847 (1993).","journal-title":"Gastroenterology"},{"key":"458_CR30","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz, T. et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295, 2275\u20132285 (2006).","journal-title":"JAMA"},{"key":"458_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/17474124.2018.1530983","volume":"12","author":"ZA Borman","year":"2018","unstructured":"Borman, Z. A., C\u00f4t\u00e9-Daigneault, J. & Colombel, J. F. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update. Expert Rev. Gastroenterol. Hepatol. 12, 1101\u20131108 (2018).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"458_CR32","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","volume":"15","author":"E Canalis","year":"2003","unstructured":"Canalis, E. Mechanisms of glucocorticoid-induced osteoporosis. Curr. Opin. Rheumatol. 15, 454\u2013457 (2003).","journal-title":"Curr. Opin. Rheumatol."},{"key":"458_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","volume":"115","author":"SE Gabriel","year":"1991","unstructured":"Gabriel, S. E., Jaakkimainen, L. & Bombardier, C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis. Ann. Intern. Med. 115, 787\u2013796 (1991).","journal-title":"Ann. Intern. Med."},{"key":"458_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jacc.2003.09.043","volume":"43","author":"PA Howard","year":"2004","unstructured":"Howard, P. A. & Delafontaine, P. Nonsteroidal anti-inflammatory drugs and cardiovascular risk. J. Am. Coll. Cardiol. 43, 519\u2013525 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"458_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.intimp.2009.11.005","volume":"10","author":"Z Bao","year":"2010","unstructured":"Bao, Z., Ye, Q., Gong, W., Xiang, Y. & Wan, H. Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int. Immunopharmacol. 10, 259\u2013263 (2010).","journal-title":"Int. Immunopharmacol."},{"key":"458_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86\u201390 (2016).","journal-title":"Nature"},{"key":"458_CR37","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"MJ Leckie","year":"2000","unstructured":"Leckie, M. J. et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356, 2144\u20132148 (2000).","journal-title":"Lancet"},{"key":"458_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1165\/ajrcmb.11.3.8086171","volume":"11","author":"R Shenkar","year":"1994","unstructured":"Shenkar, R., Coulson, W. F. & Abraham, E. Anti-transforming growth factor-beta monoclonal antibodies prevent lung injury in hemorrhaged mice. Am. J. Respir. Cell Mol. Biol. 11, 351\u2013357 (1994).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"458_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","volume":"5","author":"PC Taylor","year":"2009","unstructured":"Taylor, P. C. & Feldmann, M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 578\u2013582 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"458_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s40778-016-0044-6","volume":"2","author":"A Sargent","year":"2016","unstructured":"Sargent, A. & Miller, R. H. MSC therapeutics in chronic inflammation. Curr. Stem Cell Rep. 2, 168\u2013173 (2016).","journal-title":"Curr. Stem Cell Rep."},{"key":"458_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12712","volume":"53","author":"W Jiang","year":"2020","unstructured":"Jiang, W. & Xu, J. Immune modulation by mesenchymal stem cells. Cell Prolif. 53, e12712 (2020).","journal-title":"Cell Prolif."},{"key":"458_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry, A. et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566\u2013578 (2011).","journal-title":"Immunity"},{"key":"458_CR43","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/eji.200425405","volume":"35","author":"A Augello","year":"2005","unstructured":"Augello, A. et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35, 1482\u20131490 (2005).","journal-title":"Eur. J. Immunol."},{"key":"458_CR44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies, L. C., Heldring, N., Kadri, N. & Le Blanc, K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cell 35, 766\u2013776 (2017).","journal-title":"Stem Cell"},{"key":"458_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","volume":"23","author":"L-T Wang","year":"2016","unstructured":"Wang, L.-T. et al. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J. Biomed. Sci. 23, 76 (2016).","journal-title":"J. Biomed. Sci."},{"key":"458_CR46","doi-asserted-by":"publisher","first-page":"691329","DOI":"10.3389\/fmed.2021.691329","volume":"8","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Case report: human umbilical cord mesenchymal stem cells as a therapeutic intervention for a critically ill COVID-19 patient. Front. Med. 8, 691329 (2021).","journal-title":"Front. Med."},{"key":"458_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/AD.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng, Z. et al. Transplantation of ACE2\u2013 mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 11, 216\u2013228 (2020).","journal-title":"Aging Dis."},{"key":"458_CR48","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12015-020-09973-w","volume":"16","author":"A Golchin","year":"2020","unstructured":"Golchin, A., Seyedjafari, E. & Ardeshirylajimi, A. Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev. Rep. 16, 427\u2013433 (2020).","journal-title":"Stem Cell Rev. Rep."},{"key":"458_CR49","doi-asserted-by":"publisher","first-page":"151041","DOI":"10.1016\/j.ejcb.2019.04.002","volume":"98","author":"S Regmi","year":"2019","unstructured":"Regmi, S., Pathak, S., Kim, J. O., Yong, C. S. & Jeong, J.-H. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives. Eur. J. Cell Biol. 98, 151041 (2019).","journal-title":"Eur. J. Cell Biol."},{"key":"458_CR50","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Res. Ther. 6, 234 (2015).","journal-title":"Stem Cell Res. Ther."},{"key":"458_CR51","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney, D. G. & Pittenger, M. F. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cell 35, 851\u2013858 (2017).","journal-title":"Stem Cell"},{"key":"458_CR52","doi-asserted-by":"publisher","first-page":"9259646","DOI":"10.1155\/2016\/9259646","volume":"2016","author":"P Rider","year":"2016","unstructured":"Rider, P., Carmi, Y. & Cohen, I. Biologics for targeting inflammatory cytokines, clinical uses, and limitations. Int. J. Cell Biol. 2016, 9259646 (2016).","journal-title":"Int. J. Cell Biol."},{"key":"458_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.tips.2004.02.011","volume":"25","author":"J Vilcek","year":"2004","unstructured":"Vilcek, J. & Feldmann, M. Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol. Sci. 25, 201\u2013209 (2004).","journal-title":"Trends Pharmacol. Sci."},{"key":"458_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.10697","volume":"48","author":"ME Weinblatt","year":"2003","unstructured":"Weinblatt, M. E. et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 48, 35\u201345 (2003).","journal-title":"Arthritis Rheum."},{"key":"458_CR55","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/ni.f.210","volume":"9","author":"CR Mackay","year":"2008","unstructured":"Mackay, C. R. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat. Immunol. 9, 988\u2013998 (2008).","journal-title":"Nat. Immunol."},{"key":"458_CR56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/187152808785107633","volume":"7","author":"B Rossi","year":"2008","unstructured":"Rossi, B. & Constantin, G. Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm. Allergy Drug Targets 7, 85\u201393 (2008).","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"458_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41232-016-0013-6","volume":"36","author":"T Horiuchi","year":"2016","unstructured":"Horiuchi, T. & Tsukamoto, H. Complement-targeted therapy: development of C5- and C5a-targeted inhibition. Inflamm. Regen. 36, 11 (2016).","journal-title":"Inflamm. Regen."},{"key":"458_CR58","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/prd.12148","volume":"76","author":"PM Preshaw","year":"2018","unstructured":"Preshaw, P. M. Host modulation therapy with anti-inflammatory agents. Periodontol. 2000 76, 131\u2013149 (2018).","journal-title":"Periodontol. 2000"},{"key":"458_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ncprheum0424","volume":"3","author":"RP Taylor","year":"2007","unstructured":"Taylor, R. P. & Lindorfer, M. A. Drug insight: the mechanism of action of rituximab in autoimmune disease\u2013the immune complex decoy hypothesis. Nat. Clin. Pract. Rheumatol. 3, 86\u201395 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"458_CR60","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3748\/wjg.v24.i17.1868","volume":"24","author":"SC Park","year":"2018","unstructured":"Park, S. C. & Jeen, Y. T. Anti-integrin therapy for inflammatory bowel disease. World J. Gastroenterol. 24, 1868\u20131880 (2018).","journal-title":"World J. Gastroenterol."},{"key":"458_CR61","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","volume":"28","author":"DRW Jayne","year":"2017","unstructured":"Jayne, D. R. W. et al. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J. Am. Soc. Nephrol. 28, 2756\u20132767 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"458_CR62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.coph.2010.04.007","volume":"10","author":"K De Bosscher","year":"2010","unstructured":"De Bosscher, K., Haegeman, G. & Elewaut, D. Targeting inflammation using selective glucocorticoid receptor modulators. Curr. Opin. Pharmacol. 10, 497\u2013504 (2010).","journal-title":"Curr. Opin. Pharmacol."},{"key":"458_CR63","unstructured":"Mandavilli, A. Coronavirus can set off a \u2018cytokine storm.\u2019 These drugs may calm it. New York Times https:\/\/www.nytimes.com\/2020\/06\/11\/health\/coronavirus-cytokine-storm.html (2020)."},{"key":"458_CR64","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int. J. Pharm. 601, 120586 (2021).","journal-title":"Int. J. Pharm."},{"key":"458_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1290036","volume":"6","author":"AJ Grippin","year":"2017","unstructured":"Grippin, A. J., Sayour, E. J. & Mitchell, D. A. Translational nanoparticle engineering for cancer vaccines. Oncoimmunology 6, e1290036 (2017).","journal-title":"Oncoimmunology"},{"key":"458_CR66","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajps.2019.10.006","volume":"15","author":"J Liu","year":"2020","unstructured":"Liu, J., Miao, L., Sui, J., Hao, Y. & Huang, G. Nanoparticle cancer vaccines: design considerations and recent advances. Asian J. Pharm. Sci. 15, 576\u2013590 (2020).","journal-title":"Asian J. Pharm. Sci."},{"key":"458_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","volume":"105","author":"T Ishida","year":"2005","unstructured":"Ishida, T. et al. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J. Control. Release 105, 305\u2013317 (2005).","journal-title":"J. Control. Release"},{"key":"458_CR68","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"N Naseri","year":"2015","unstructured":"Naseri, N., Valizadeh, H. & Zakeri-Milani, P. Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application. Adv. Pharm. Bull. 5, 305\u2013313 (2015).","journal-title":"Adv. Pharm. Bull."},{"key":"458_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"458_CR70","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2147\/DDDT.S165440","volume":"12","author":"R Song","year":"2018","unstructured":"Song, R. et al. Current development of biodegradable polymeric materials for biomedical applications. Drug Des. Devel Ther. 12, 3117\u20133145 (2018).","journal-title":"Drug Des. Devel Ther."},{"key":"458_CR71","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1039\/C4NR07682F","volume":"7","author":"U Ikoba","year":"2015","unstructured":"Ikoba, U. et al. Nanocarriers in therapy of infectious and inflammatory diseases. Nanoscale 7, 4291\u20134305 (2015).","journal-title":"Nanoscale"},{"key":"458_CR72","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.colsurfb.2014.09.029","volume":"123","author":"JO Eloy","year":"2014","unstructured":"Eloy, J. O. et al. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloids Surf. B 123, 345\u2013363 (2014).","journal-title":"Colloids Surf. B"},{"key":"458_CR73","doi-asserted-by":"publisher","first-page":"1900133","DOI":"10.1002\/advs.201900133","volume":"6","author":"G Hannon","year":"2019","unstructured":"Hannon, G., Lysaght, J., Liptrott, N. J. & Prina-Mello, A. Immunotoxicity considerations for next generation cancer nanomedicines. Adv. Sci. 6, 1900133 (2019).","journal-title":"Adv. Sci."},{"key":"458_CR74","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","volume":"22","author":"M Cagel","year":"2017","unstructured":"Cagel, M., Grotz, E., Bernabeu, E., Moretton, M. A. & Chiappetta, D. A. Doxorubicin: nanotechnological overviews from bench to bedside. Drug Discov. Today 22, 270\u2013281 (2017).","journal-title":"Drug Discov. Today"},{"key":"458_CR75","doi-asserted-by":"crossref","unstructured":"Nardo, D., Henson, D., Springer, J. E. & Venditto, V. J. in Nanomaterials for Clinical Applications (eds Pippa, N. & Demetzos, C.) 159\u2013211 (Elsevier, 2020).","DOI":"10.1016\/B978-0-12-816705-2.00006-0"},{"key":"458_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","volume":"213","author":"PH Kierstead","year":"2015","unstructured":"Kierstead, P. H. et al. The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes. J. Control. Release 213, 1\u20139 (2015).","journal-title":"J. Control. Release"},{"key":"458_CR77","first-page":"607","volume":"298","author":"P Laverman","year":"2001","unstructured":"Laverman, P. et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J. Pharmacol. Exp. Ther. 298, 607 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"458_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10717544.2019.1701141","volume":"27","author":"J Hao","year":"2020","unstructured":"Hao, J. et al. Neutrophils, as \u201cTrojan horses\u201d, participate in the delivery of therapeutical PLGA nanoparticles into a tumor based on the chemotactic effect. Drug Deliv. 27, 1\u201314 (2020).","journal-title":"Drug Deliv."},{"key":"458_CR79","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1021\/acs.molpharmaceut.9b00860","volume":"16","author":"P Gu","year":"2019","unstructured":"Gu, P. et al. Rational design of PLGA nanoparticle vaccine delivery systems to improve immune responses. Mol. Pharm. 16, 5000\u20135012 (2019).","journal-title":"Mol. Pharm."},{"key":"458_CR80","doi-asserted-by":"publisher","first-page":"1601418","DOI":"10.1002\/adhm.201601418","volume":"6","author":"BA Bailey","year":"2017","unstructured":"Bailey, B. A., Ochyl, L. J., Schwendeman, S. P. & Moon, J. J. Toward a single-dose vaccination strategy with self-encapsulating PLGA microspheres. Adv. Healthc. Mater. 6, 1601418 (2017).","journal-title":"Adv. Healthc. Mater."},{"key":"458_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","volume":"16","author":"A Cifuentes-Rius","year":"2021","unstructured":"Cifuentes-Rius, A., Desai, A., Yuen, D., Johnston, A. P. R. & Voelcker, N. H. Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nat. Nanotechnol. 16, 37\u201346 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"458_CR82","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/jbm.a.31019","volume":"81","author":"S Hamdy","year":"2007","unstructured":"Hamdy, S. et al. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and Toll-like receptor ligand monophosphoryl lipid A in poly(d,l-lactic-co-glycolic acid) nanoparticles. J. Biomed. Mater. Res. Part A 81, 652\u2013662 (2007).","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"458_CR83","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/acs.nanolett.9b03483","volume":"20","author":"S Son","year":"2020","unstructured":"Son, S. et al. Sugar-nanocapsules imprinted with microbial molecular patterns for mRNA vaccination. Nano Lett. 20, 1499\u20131509 (2020).","journal-title":"Nano Lett."},{"key":"458_CR84","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1208\/s12249-019-1526-5","volume":"21","author":"J Zhu","year":"2019","unstructured":"Zhu, J. et al. Mannose-modified PLGA nanoparticles for sustained and targeted delivery in hepatitis b virus immunoprophylaxis. AAPS PharmSciTech 21, 13 (2019).","journal-title":"AAPS PharmSciTech"},{"key":"458_CR85","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1021\/acsabm.9b00092","volume":"2","author":"R Allen","year":"2019","unstructured":"Allen, R., Chizari, S., Ma, J. A., Raychaudhuri, S. & Lewis, J. S. Combinatorial, microparticle-based delivery of immune modulators reprograms the dendritic cell phenotype and promotes remission of collagen-induced arthritis in mice. ACS Appl. Bio Mater. 2, 2388\u20132404 (2019).","journal-title":"ACS Appl. Bio Mater."},{"key":"458_CR86","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1021\/acsbiomaterials.9b00332","volume":"5","author":"JS Lewis","year":"2019","unstructured":"Lewis, J. S. et al. Dual-sized microparticle system for generating suppressive dendritic cells prevents and reverses type 1 diabetes in the nonobese diabetic mouse model. ACS Biomater. Sci. Eng. 5, 2631\u20132646 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"458_CR87","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","volume":"4","author":"A Schudel","year":"2019","unstructured":"Schudel, A., Francis, D. M. & Thomas, S. N. Material design for lymph node drug delivery. Nat. Rev. Mater. 4, 415\u2013428 (2019).","journal-title":"Nat. Rev. Mater."},{"key":"458_CR88","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1021\/acs.bioconjchem.7b00624","volume":"29","author":"LM Casey","year":"2018","unstructured":"Casey, L. M. et al. Conjugation of transforming growth factor beta to antigen-loaded poly(lactide-co-glycolide) nanoparticles enhances efficiency of antigen-specific tolerance. Bioconjug. Chem. 29, 813\u2013823 (2018).","journal-title":"Bioconjug. Chem."},{"key":"458_CR89","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","volume":"16","author":"LisaH Tostanoski","year":"2016","unstructured":"Tostanoski, LisaH. et al. Reprogramming the local lymph node microenvironment promotes tolerance that is systemic and antigen specific. Cell Rep. 16, 2940\u20132952 (2016).","journal-title":"Cell Rep."},{"key":"458_CR90","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2015.03.023","volume":"160","author":"JS Lewis","year":"2015","unstructured":"Lewis, J. S. et al. A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice. Clin. Immunol. 160, 90\u2013102 (2015).","journal-title":"Clin. Immunol."},{"key":"458_CR91","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1039\/C7TB03080K","volume":"6","author":"X Chen","year":"2018","unstructured":"Chen, X. & Gao, C. Influences of surface coating of PLGA nanoparticles on immune activation of macrophages. J. Mater. Chem. B 6, 2065\u20132077 (2018).","journal-title":"J. Mater. Chem. B"},{"key":"458_CR92","doi-asserted-by":"publisher","first-page":"19436","DOI":"10.1021\/acsami.8b04718","volume":"10","author":"Y-J Huang","year":"2018","unstructured":"Huang, Y.-J., Hung, K.-C., Hung, H.-S. & Hsu, S.-h. Modulation of macrophage phenotype by biodegradable polyurethane nanoparticles: possible relation between macrophage polarization and immune response of nanoparticles. ACS Appl. Mater. Interf. 10, 19436\u201319448 (2018).","journal-title":"ACS Appl. Mater. Interf."},{"key":"458_CR93","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ijpharm.2011.10.034","volume":"422","author":"KJ Kauffman","year":"2012","unstructured":"Kauffman, K. J. et al. Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression. Int. J. Pharm. 422, 356\u2013363 (2012).","journal-title":"Int. J. Pharm."},{"key":"458_CR94","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1039\/D0BM00596G","volume":"8","author":"KM Dhanabalan","year":"2020","unstructured":"Dhanabalan, K. M., Gupta, V. K. & Agarwal, R. Rapamycin\u2013PLGA microparticles prevent senescence, sustain cartilage matrix production under stress and exhibit prolonged retention in mouse joints. Biomater. Sci. 8, 4308\u20134321 (2020).","journal-title":"Biomater. Sci."},{"key":"458_CR95","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jconrel.2020.02.030","volume":"321","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis. J. Control. Release 321, 463\u2013474 (2020).","journal-title":"J. Control. Release"},{"key":"458_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2021.07.010","volume":"337","author":"A Garc\u00eda-Fern\u00e1ndez","year":"2021","unstructured":"Garc\u00eda-Fern\u00e1ndez, A. et al. Targeted-lung delivery of dexamethasone using gated mesoporous silica nanoparticles: a new therapeutic approach for acute lung injury treatment. J. Control. Release 337, 14\u201326 (2021).","journal-title":"J. Control. Release"},{"key":"458_CR97","doi-asserted-by":"publisher","first-page":"16380","DOI":"10.1021\/acsami.9b04051","volume":"11","author":"CY Zhang","year":"2019","unstructured":"Zhang, C. Y. et al. pH-responsive nanoparticles targeted to lungs for improved therapy of acute lung inflammation\/injury. ACS Appl. Mater. Interf. 11, 16380\u201316390 (2019).","journal-title":"ACS Appl. Mater. Interf."},{"key":"458_CR98","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.2147\/IJN.S140992","volume":"12","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int. J. Nanomed. 12, 6735\u20136746 (2017).","journal-title":"Int. J. Nanomed."},{"key":"458_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1021\/bc700227z","volume":"19","author":"N Zhang","year":"2008","unstructured":"Zhang, N., Chittasupho, C., Duangrat, C., Siahaan, T. J. & Berkland, C. PLGA nanoparticle\u2212peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjug. Chem. 19, 145\u2013152 (2008).","journal-title":"Bioconjug. Chem."},{"key":"458_CR100","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nri2171","volume":"7","author":"JS Pober","year":"2007","unstructured":"Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803\u2013815 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR101","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678\u2013689 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR102","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1021\/nn500136z","volume":"8","author":"M Howard","year":"2014","unstructured":"Howard, M. et al. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano 8, 4100\u20134132 (2014).","journal-title":"ACS Nano"},{"key":"458_CR103","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.apsb.2017.12.002","volume":"8","author":"K Jin","year":"2018","unstructured":"Jin, K., Luo, Z., Zhang, B. & Pang, Z. Biomimetic nanoparticles for inflammation targeting. Acta Pharm. Sin. B 8, 23\u201333 (2018).","journal-title":"Acta Pharm. Sin. B"},{"key":"458_CR104","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.biomaterials.2004.03.003","volume":"26","author":"AOAO Eniola","year":"2005","unstructured":"Eniola, A. O. A. O. & Hammer, D. A. D. A. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity. Biomaterials 26, 661\u2013670 (2005).","journal-title":"Biomaterials"},{"key":"458_CR105","doi-asserted-by":"publisher","first-page":"15895","DOI":"10.1073\/pnas.2631433100","volume":"100","author":"HS Sakhalkar","year":"2003","unstructured":"Sakhalkar, H. S. et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc. Natl Acad. Sci. USA 100, 15895\u201315900 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"458_CR106","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.1016\/j.biomaterials.2005.05.005","volume":"26","author":"A Omolola Eniola","year":"2005","unstructured":"Omolola Eniola, A. & Hammer, D. A. In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors. Biomaterials 26, 7136\u20137144 (2005).","journal-title":"Biomaterials"},{"key":"458_CR107","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/btm2.10008","volume":"1","author":"CA Fromen","year":"2016","unstructured":"Fromen, C. A. et al. Evaluation of receptor-ligand mechanisms of dual-targeted particles to an inflamed endothelium. Bioeng. Transl. Med. 1, 103\u2013115 (2016).","journal-title":"Bioeng. Transl. Med."},{"key":"458_CR108","doi-asserted-by":"publisher","first-page":"6530","DOI":"10.1021\/acsbiomaterials.9b01289","volume":"5","author":"WJ Kelley","year":"2019","unstructured":"Kelley, W. J., Onyskiw, P. J., Fromen, C. A. & Eniola-Adefeso, O. Model particulate drug carriers modulate leukocyte adhesion in human blood flows. ACS Biomater. Sci. Eng. 5, 6530\u20136540 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"458_CR109","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.1021\/acsnano.7b03190","volume":"11","author":"CA Fromen","year":"2017","unstructured":"Fromen, C. A. et al. Neutrophil\u2013particle interactions in blood circulation drive particle clearance and alter neutrophil responses in acute inflammation. ACS Nano 11, 10797\u201310807 (2017).","journal-title":"ACS Nano"},{"key":"458_CR110","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.biomaterials.2009.11.007","volume":"31","author":"P Charoenphol","year":"2010","unstructured":"Charoenphol, P., Huang, R. B. & Eniola-Adefeso, O. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. Biomaterials 31, 1392\u20131402 (2010).","journal-title":"Biomaterials"},{"key":"458_CR111","doi-asserted-by":"publisher","first-page":"042217","DOI":"10.1063\/1.5027760","volume":"12","author":"M Gutierrez","year":"2018","unstructured":"Gutierrez, M., Ojeda, L. S. & Eniola-Adefeso, O. Vascular-targeted particle binding efficacy in the presence of rigid red blood cells: implications for performance in diseased blood. Biomicrofluidics 12, 042217 (2018).","journal-title":"Biomicrofluidics"},{"key":"458_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/srep04871","volume":"4","author":"K M\u00fcller","year":"2014","unstructured":"M\u00fcller, K., Fedosov, D. A. & Gompper, G. Margination of micro- and nano-particles in blood flow and its effect on drug delivery. Sci. Rep. 4, 4871 (2014).","journal-title":"Sci. Rep."},{"key":"458_CR113","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.actbio.2015.04.005","volume":"21","author":"AJ Thompson","year":"2015","unstructured":"Thompson, A. J. & Eniola-Adefeso, O. Dense nanoparticles exhibit enhanced vascular wall targeting over neutrally buoyant nanoparticles in human blood flow. Acta Biomater. 21, 99\u2013108 (2015).","journal-title":"Acta Biomater."},{"key":"458_CR114","doi-asserted-by":"publisher","first-page":"119333","DOI":"10.1016\/j.biomaterials.2019.119333","volume":"218","author":"LM Casey","year":"2019","unstructured":"Casey, L. M. et al. Cargo-less nanoparticles program innate immune cell responses to Toll-like receptor activation. Biomaterials 218, 119333 (2019).","journal-title":"Biomaterials"},{"key":"458_CR115","doi-asserted-by":"publisher","first-page":"14947","DOI":"10.1073\/pnas.1820276116","volume":"116","author":"J Park","year":"2019","unstructured":"Park, J. et al. Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury. Proc. Natl Acad. Sci. USA 116, 14947 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"458_CR116","doi-asserted-by":"publisher","first-page":"119987","DOI":"10.1016\/j.biomaterials.2020.119987","volume":"245","author":"L Lu","year":"2020","unstructured":"Lu, L. et al. Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis. Biomaterials 245, 119987 (2020).","journal-title":"Biomaterials"},{"key":"458_CR117","doi-asserted-by":"publisher","first-page":"2101534","DOI":"10.1002\/adhm.202101534","volume":"11","author":"ER Brannon","year":"2022","unstructured":"Brannon, E. R. et al. Poly-salicylic acid polymer microparticle decoys therapeutically treat acute respiratory distress syndrome. Adv. Healthc. Mater. 11, 2101534 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"458_CR118","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12195-020-00652-x","volume":"13","author":"R Sangsuwan","year":"2020","unstructured":"Sangsuwan, R. et al. Lactate exposure promotes immunosuppressive phenotypes in innate immune cells. Cell. Mol. Bioeng. 13, 541\u2013557 (2020).","journal-title":"Cell. Mol. Bioeng."},{"key":"458_CR119","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1021\/acsbiomaterials.8b01062","volume":"4","author":"PW Bisso","year":"2018","unstructured":"Bisso, P. W., Gaglione, S., Guimar\u00e3es, P. P. G., Mitchell, M. J. & Langer, R. Nanomaterial interactions with human neutrophils. ACS Biomater. Sci. Eng. 4, 4255\u20134265 (2018).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"458_CR120","doi-asserted-by":"publisher","first-page":"eaba1474","DOI":"10.1126\/sciadv.aba1474","volume":"6","author":"H Safari","year":"2020","unstructured":"Safari, H. et al. Neutrophils preferentially phagocytose elongated particles \u2014 an opportunity for selective targeting in acute inflammatory diseases. Sci. Adv. 6, eaba1474 (2020).","journal-title":"Sci. Adv."},{"key":"458_CR121","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1021\/acsbiomaterials.7b00831","volume":"4","author":"RP Allen","year":"2018","unstructured":"Allen, R. P., Bolandparvaz, A., Ma, J. A., Manickam, V. A. & Lewis, J. S. Latent, immunosuppressive nature of poly(lactic-co-glycolic acid) microparticles. ACS Biomater. Sci. Eng. 4, 900\u2013918 (2018).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"458_CR122","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier, F. et al. PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 161, 505\u2013522 (2012).","journal-title":"J. Control. Release"},{"key":"458_CR123","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","volume":"304","author":"K Park","year":"2019","unstructured":"Park, K. et al. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. J. Control. Release 304, 125\u2013134 (2019).","journal-title":"J. Control. Release"},{"key":"458_CR124","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.intimp.2011.05.014","volume":"11","author":"R Nicolete","year":"2011","unstructured":"Nicolete, R., dos Santos, D. F. & Faccioli, L. H. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. Int. Immunopharmacol. 11, 1557\u20131563 (2011).","journal-title":"Int. Immunopharmacol."},{"key":"458_CR125","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jconrel.2016.04.039","volume":"233","author":"D Jeong","year":"2016","unstructured":"Jeong, D. et al. Porous antioxidant polymer microparticles as therapeutic systems for the airway inflammatory diseases. J. Control. Release 233, 72\u201380 (2016).","journal-title":"J. Control. Release"},{"key":"458_CR126","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2147\/DDDT.S133344","volume":"11","author":"J-S Baek","year":"2017","unstructured":"Baek, J.-S., Yeo, E. W., Lee, Y. H., Tan, N. S. & Loo, S. C. J. Controlled-release nanoencapsulating microcapsules to combat inflammatory diseases. Drug Des. Dev. Ther. 11, 1707\u20131717 (2017).","journal-title":"Drug Des. Dev. Ther."},{"key":"458_CR127","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1021\/acsbiomaterials.8b01510","volume":"5","author":"Y Nakagawa","year":"2019","unstructured":"Nakagawa, Y. et al. Apoptotic cell-inspired polymeric particles for controlling microglial inflammation toward neurodegenerative disease treatment. ACS Biomater. Sci. Eng. 5, 5705\u20135713 (2019).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"458_CR128","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1015623108","volume":"108","author":"T Harel-Adar","year":"2011","unstructured":"Harel-Adar, T. et al. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl Acad. Sci. USA 108, 1827 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"458_CR129","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0142-9612(00)00073-9","volume":"21","author":"L Erdmann","year":"2000","unstructured":"Erdmann, L. & Uhrich, K. E. Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters). Biomaterials 21, 1941\u20131946 (2000).","journal-title":"Biomaterials"},{"key":"458_CR130","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1021\/bm400889a","volume":"14","author":"R Rosario-Mel\u00e9ndez","year":"2013","unstructured":"Rosario-Mel\u00e9ndez, R., Yu, W. & Uhrich, K. E. Biodegradable polyesters containing ibuprofen and naproxen as pendant groups. Biomacromolecules 14, 3542\u20133548 (2013).","journal-title":"Biomacromolecules"},{"key":"458_CR131","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00289-012-0839-2","volume":"70","author":"R Rosario-Mel\u00e9ndez","year":"2013","unstructured":"Rosario-Mel\u00e9ndez, R., Ouimet, M. A. & Uhrich, K. E. Formulation of salicylate-based poly(anhydride-ester) microspheres for short- and long-term salicylic acid delivery. Polym. Bull. 70, 343\u2013351 (2013).","journal-title":"Polym. Bull."},{"key":"458_CR132","doi-asserted-by":"publisher","first-page":"21076","DOI":"10.1021\/acsami.1c04953","volume":"13","author":"L He","year":"2021","unstructured":"He, L. et al. Dual-stimuli responsive polymeric micelles for the effective treatment of rheumatoid arthritis. ACS Appl. Mater. Interf. 13, 21076\u201321086 (2021).","journal-title":"ACS Appl. Mater. Interf."},{"key":"458_CR133","doi-asserted-by":"publisher","first-page":"40378","DOI":"10.1021\/acsami.8b08254","volume":"10","author":"S Lee","year":"2018","unstructured":"Lee, S., Stubelius, A., Hamelmann, N., Tran, V. & Almutairi, A. Inflammation-responsive drug-conjugated dextran nanoparticles enhance anti-inflammatory drug efficacy. ACS Appl. Mater. Interf. 10, 40378\u201340387 (2018).","journal-title":"ACS Appl. Mater. Interf."},{"key":"458_CR134","doi-asserted-by":"publisher","first-page":"2105089","DOI":"10.1002\/adfm.202105089","volume":"31","author":"L Zhu","year":"2021","unstructured":"Zhu, L. et al. Dynamically deformable protein delivery strategy disassembles neutrophil extracellular traps to prevent liver metastasis. Adv. Funct. Mater. 31, 2105089 (2021).","journal-title":"Adv. Funct. Mater."},{"key":"458_CR135","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.biomaterials.2014.11.016","volume":"41","author":"KM Poole","year":"2015","unstructured":"Poole, K. M. et al. ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease. Biomaterials 41, 166\u2013175 (2015).","journal-title":"Biomaterials"},{"key":"458_CR136","doi-asserted-by":"publisher","first-page":"2000129","DOI":"10.1002\/adtp.202000129","volume":"3","author":"N Pacifici","year":"2020","unstructured":"Pacifici, N., Bolandparvaz, A. & Lewis, J. S. Stimuli-responsive biomaterials for vaccines and immunotherapeutic applications. Adv. Ther. 3, 2000129 (2020).","journal-title":"Adv. Ther."},{"key":"458_CR137","first-page":"35","volume":"1","author":"T Malachowski","year":"2020","unstructured":"Malachowski, T. & Hassel, A. Engineering nanoparticles to overcome immunological barriers for enhanced drug delivery. Eng. Regen. 1, 35\u201350 (2020).","journal-title":"Eng. Regen."},{"key":"458_CR138","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","volume":"25","author":"JA Champion","year":"2008","unstructured":"Champion, J. A., Walker, A. & Mitragotri, S. Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res. 25, 1815\u20131821 (2008).","journal-title":"Pharm. Res."},{"key":"458_CR139","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3762\/bjnano.5.174","volume":"5","author":"DA Kuhn","year":"2014","unstructured":"Kuhn, D. A. et al. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J. Nanotechnol. 5, 1625\u20131636 (2014).","journal-title":"Beilstein J. Nanotechnol."},{"key":"458_CR140","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0304-4165(86)90020-6","volume":"881","author":"MK Pratten","year":"1986","unstructured":"Pratten, M. K. & Lloyd, J. B. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim. Biophys. Acta Gen. Subj. 881, 307\u2013313 (1986).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"458_CR141","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","volume":"157","author":"R Brusini","year":"2020","unstructured":"Brusini, R., Varna, M. & Couvreur, P. Advanced nanomedicines for the treatment of inflammatory diseases. Adv. Drug Deliv. Rev. 157, 161\u2013178 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"458_CR142","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1046\/j.1460-9568.2002.01967.x","volume":"15","author":"P Calvo","year":"2002","unstructured":"Calvo, P. et al. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur. J. Neurosci. 15, 1317\u20131326 (2002).","journal-title":"Eur. J. Neurosci."},{"key":"458_CR143","doi-asserted-by":"publisher","first-page":"15863","DOI":"10.1039\/C5NR03626G","volume":"7","author":"KH Chen","year":"2015","unstructured":"Chen, K. H. et al. Nanoparticle distribution during systemic inflammation is size-dependent and organ-specific. Nanoscale 7, 15863\u201315872 (2015).","journal-title":"Nanoscale"},{"key":"458_CR144","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2015.12.015","volume":"498","author":"J Pradal","year":"2016","unstructured":"Pradal, J. et al. Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice. Int. J. Pharm. 498, 119\u2013129 (2016).","journal-title":"Int. J. Pharm."},{"key":"458_CR145","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1021\/la304746p","volume":"29","author":"K Namdee","year":"2013","unstructured":"Namdee, K., Thompson, A. J., Charoenphol, P. & Eniola-Adefeso, O. Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels. Langmuir 29, 2530\u20132535 (2013).","journal-title":"Langmuir"},{"key":"458_CR146","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/09687688.2010.499548","volume":"27","author":"RB Huang","year":"2010","unstructured":"Huang, R. B., Mocherla, S., Heslinga, M. J., Charoenphol, P. & Eniola-Adefeso, O. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review). Mol. Membr. Biol. 27, 190\u2013205 (2010).","journal-title":"Mol. Membr. Biol."},{"key":"458_CR147","doi-asserted-by":"publisher","first-page":"219ra217","DOI":"10.1126\/scitranslmed.3007563","volume":"6","author":"DR Getts","year":"2014","unstructured":"Getts, D. R. et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci. Transl Med. 6, 219ra217 (2014).","journal-title":"Sci. Transl Med."},{"key":"458_CR148","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1073\/pnas.0600997103","volume":"103","author":"JA Champion","year":"2006","unstructured":"Champion, J. A. & Mitragotri, S. Role of target geometry in phagocytosis. Proc. Natl Acad. Sci. USA 103, 4930 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"458_CR149","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11095-008-9626-z","volume":"26","author":"JA Champion","year":"2009","unstructured":"Champion, J. A. & Mitragotri, S. Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res. 26, 244\u2013249 (2009).","journal-title":"Pharm. Res."},{"key":"458_CR150","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.2174\/138161210791920496","volume":"16","author":"JW Yoo","year":"2010","unstructured":"Yoo, J. W., Chambers, E. & Mitragotri, S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr. Pharm. Des. 16, 2298\u20132307 (2010).","journal-title":"Curr. Pharm. Des."},{"key":"458_CR151","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1021\/nl403949h","volume":"14","author":"S Dasgupta","year":"2014","unstructured":"Dasgupta, S., Auth, T. & Gompper, G. Shape and orientation matter for the cellular uptake of nonspherical particles. Nano Lett. 14, 687\u2013693 (2014).","journal-title":"Nano Lett."},{"key":"458_CR152","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jconrel.2010.07.116","volume":"147","author":"G Sharma","year":"2010","unstructured":"Sharma, G. et al. Polymer particle shape independently influences binding and internalization by macrophages. J. Control. Release 147, 408\u2013412 (2010).","journal-title":"J. Control. Release"},{"key":"458_CR153","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.1039\/C8NR04042G","volume":"10","author":"M Cooley","year":"2018","unstructured":"Cooley, M. et al. Influence of particle size and shape on their margination and wall-adhesion: implications in drug delivery vehicle design across nano-to-micro scale. Nanoscale 10, 15350\u201315364 (2018).","journal-title":"Nanoscale"},{"key":"458_CR154","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.atherosclerosis.2014.09.025","volume":"237","author":"K Namdee","year":"2014","unstructured":"Namdee, K. et al. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis. Atherosclerosis 237, 279\u2013286 (2014).","journal-title":"Atherosclerosis"},{"key":"458_CR155","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1016\/j.biomaterials.2013.04.011","volume":"34","author":"AJ Thompson","year":"2013","unstructured":"Thompson, A. J., Mastria, E. M. & Eniola-Adefeso, O. The margination propensity of ellipsoidal micro\/nanoparticles to the endothelium in human blood flow. Biomaterials 34, 5863\u20135871 (2013).","journal-title":"Biomaterials"},{"key":"458_CR156","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2019.07.026","volume":"309","author":"A Da Silva-Candal","year":"2019","unstructured":"Da Silva-Candal, A. et al. Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions. J. Control. Release 309, 94\u2013105 (2019).","journal-title":"J. Control. Release"},{"key":"458_CR157","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1073\/pnas.1308345110","volume":"110","author":"P Kolhar","year":"2013","unstructured":"Kolhar, P. et al. Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc. Natl Acad. Sci. USA 110, 10753 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"458_CR158","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nnano.2017.47","volume":"12","author":"PP Wibroe","year":"2017","unstructured":"Wibroe, P. P. et al. Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat. Nanotechnol. 12, 589\u2013594 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"458_CR159","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0939-6411(02)00081-4","volume":"54","author":"A Gessner","year":"2002","unstructured":"Gessner, A., Lieske, A., Paulke, B. & M\u00fcller, R. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur. J. Pharm. Biopharm. 54, 165\u2013170 (2002).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"458_CR160","doi-asserted-by":"publisher","first-page":"48284","DOI":"10.1021\/acsami.0c12341","volume":"12","author":"SM Pustulka","year":"2020","unstructured":"Pustulka, S. M., Ling, K., Pish, S. L. & Champion, J. A. Protein nanoparticle charge and hydrophobicity govern protein corona and macrophage uptake. ACS Appl. Mater. Interf. 12, 48284\u201348295 (2020).","journal-title":"ACS Appl. Mater. Interf."},{"key":"458_CR161","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/ja2084338","volume":"134","author":"CD Walkey","year":"2012","unstructured":"Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. & Chan, W. C. W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139\u20132147 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"458_CR162","doi-asserted-by":"publisher","first-page":"5304","DOI":"10.1021\/nl302638g","volume":"12","author":"JL Perry","year":"2012","unstructured":"Perry, J. L. et al. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett. 12, 5304\u20135310 (2012).","journal-title":"Nano Lett."},{"key":"458_CR163","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1021\/mp400703d","volume":"11","author":"Q Yang","year":"2014","unstructured":"Yang, Q. et al. Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. Mol. Pharm. 11, 1250\u20131258 (2014).","journal-title":"Mol. Pharm."},{"key":"458_CR164","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s11095-015-1701-7","volume":"32","author":"TW Shen","year":"2015","unstructured":"Shen, T. W. et al. Distribution and cellular uptake of PEGylated polymeric particles in the lung towards cell-specific targeted delivery. Pharm. Res. 32, 3248\u20133260 (2015).","journal-title":"Pharm. Res."},{"key":"458_CR165","doi-asserted-by":"publisher","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","volume":"13","author":"GT Kozma","year":"2019","unstructured":"Kozma, G. T. et al. Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions. ACS Nano 13, 9315\u20139324 (2019).","journal-title":"ACS Nano"},{"key":"458_CR166","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2010.04.003","volume":"146","author":"SM Moghimi","year":"2010","unstructured":"Moghimi, S. M. et al. Complement activation cascade triggered by PEG\u2013PL engineered nanomedicines and carbon nanotubes: the challenges ahead. J. Control. Release 146, 175\u2013181 (2010).","journal-title":"J. Control. Release"},{"key":"458_CR167","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","volume":"137","author":"NJ Ganson","year":"2016","unstructured":"Ganson, N. J. et al. Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer. J. Allergy Clin. Immunol. 137, 1610\u20131613.e7 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"458_CR168","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","volume":"9","author":"P Sellaturay","year":"2021","unstructured":"Sellaturay, P., Nasser, S. & Ewan, P. Polyethylene glycol-induced systemic allergic reactions (anaphylaxis). J. Allergy Clin. Immunol. Pract. 9, 670\u2013675 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"458_CR169","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cea.13874","volume":"51","author":"P Sellaturay","year":"2021","unstructured":"Sellaturay, P., Nasser, S., Islam, S., Gurugama, P. & Ewan, P. W. Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine. Clin. Exp. Allergy 51, 861\u2013863 (2021).","journal-title":"Clin. Exp. Allergy"},{"key":"458_CR170","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk, J. S., Xu, Q., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28\u201351 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"458_CR171","first-page":"1071","volume":"292","author":"ET Dams","year":"2000","unstructured":"Dams, E. T. et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J. Pharmacol. Exp. Ther. 292, 1071\u20131079 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"458_CR172","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jconrel.2006.01.005","volume":"112","author":"T Ishida","year":"2006","unstructured":"Ishida, T. et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J. Control. Release 112, 15\u201325 (2006).","journal-title":"J. Control. Release"},{"key":"458_CR173","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1002\/anie.200902672","volume":"49","author":"K Knop","year":"2010","unstructured":"Knop, K., Hoogenboom, R., Fischer, D. & Schubert, U. S. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 49, 6288\u20136308 (2010).","journal-title":"Angew. Chem. Int. Ed."},{"key":"458_CR174","doi-asserted-by":"publisher","first-page":"eabd7563","DOI":"10.1126\/sciadv.abd7563","volume":"6","author":"M Hamadani Christine","year":"2020","unstructured":"Hamadani Christine, M., Goetz Morgan, J., Mitragotri, S. & Tanner Eden, E. L. Protein-avoidant ionic liquid (PAIL)\u2013coated nanoparticles to increase bloodstream circulation and drive biodistribution. Sci. Adv. 6, eabd7563 (2020).","journal-title":"Sci. Adv."},{"key":"458_CR175","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.actbio.2018.09.001","volume":"79","author":"WJ Kelley","year":"2018","unstructured":"Kelley, W. J., Fromen, C. A., Lopez-Cazares, G. & Eniola-Adefeso, O. PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils. Acta Biomater. 79, 283\u2013293 (2018).","journal-title":"Acta Biomater."},{"key":"458_CR176","doi-asserted-by":"publisher","first-page":"8821","DOI":"10.1021\/la8005844","volume":"24","author":"JB Haun","year":"2008","unstructured":"Haun, J. B. & Hammer, D. A. Quantifying nanoparticle adhesion mediated by specific molecular interactions. Langmuir 24, 8821\u20138832 (2008).","journal-title":"Langmuir"},{"key":"458_CR177","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1021\/nn305773f","volume":"7","author":"BJ Zern","year":"2013","unstructured":"Zern, B. J. et al. Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation. ACS Nano 7, 2461\u20132469 (2013).","journal-title":"ACS Nano"},{"key":"458_CR178","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.addr.2016.01.007","volume":"108","author":"AC Anselmo","year":"2017","unstructured":"Anselmo, A. C. & Mitragotri, S. Impact of particle elasticity on particle-based drug delivery systems. Adv. Drug Deliv. Rev. 108, 51\u201367 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"458_CR179","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.biomaterials.2017.02.002","volume":"124","author":"MB Fish","year":"2017","unstructured":"Fish, M. B. et al. Exploring deformable particles in vascular-targeted drug delivery: softer is only sometimes better. Biomaterials 124, 169\u2013179 (2017).","journal-title":"Biomaterials"},{"key":"458_CR180","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02588-9","volume":"9","author":"P Guo","year":"2018","unstructured":"Guo, P. et al. Nanoparticle elasticity directs tumor uptake. Nat. Commun. 9, 130 (2018).","journal-title":"Nat. Commun."},{"key":"458_CR181","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1021\/acsnano.5b00147","volume":"9","author":"AC Anselmo","year":"2015","unstructured":"Anselmo, A. C. et al. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 9, 3169\u20133177 (2015).","journal-title":"ACS Nano"},{"key":"458_CR182","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1242\/jcs.115.4.849","volume":"115","author":"KA Beningo","year":"2002","unstructured":"Beningo, K. A. & Wang, Y. L. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 115, 849\u2013856 (2002).","journal-title":"J. Cell Sci."},{"key":"458_CR183","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1021\/acsnano.5b04866","volume":"9","author":"J Key","year":"2015","unstructured":"Key, J. et al. Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors. ACS Nano 9, 11628\u201311641 (2015).","journal-title":"ACS Nano"},{"key":"458_CR184","doi-asserted-by":"publisher","first-page":"eabe0143","DOI":"10.1126\/sciadv.abe0143","volume":"7","author":"MB Fish","year":"2021","unstructured":"Fish, M. B. et al. Deformable microparticles for shuttling nanoparticles to the vascular wall. Sci. Adv. 7, eabe0143 (2021).","journal-title":"Sci. Adv."},{"key":"458_CR185","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.surg.2011.07.059","volume":"150","author":"AM Bachelani","year":"2011","unstructured":"Bachelani, A. M. et al. Assessment of platelet transfusion for reversal of aspirin after traumatic brain injury. Surgery 150, 836\u2013843 (2011).","journal-title":"Surgery"},{"key":"458_CR186","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/neu.2017.5194","volume":"35","author":"JA Huijben","year":"2018","unstructured":"Huijben, J. A. et al. Variation in blood transfusion and coagulation management in traumatic brain injury at the intensive care unit: a survey in 66 neurotrauma centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Study. J. Neurotrauma 35, 323\u2013332 (2018).","journal-title":"J. Neurotrauma"},{"key":"458_CR187","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1002\/jbm.b.34888","volume":"109","author":"J Todd","year":"2021","unstructured":"Todd, J. et al. Platelet-like particles reduce coagulopathy-related and neuroinflammatory pathologies post-experimental traumatic brain injury. J. Biomed. Mater. Res. B 109, 2268\u20132278 (2021).","journal-title":"J. Biomed. Mater. Res. B"},{"key":"458_CR188","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.cej.2018.07.126","volume":"353","author":"A Shah","year":"2018","unstructured":"Shah, A. et al. Stimuli-responsive peptide-based biomaterials as drug delivery systems. Chem. Eng. J. 353, 559\u2013583 (2018).","journal-title":"Chem. Eng. J."},{"key":"458_CR189","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2016.05.020","volume":"107","author":"BK Lee","year":"2016","unstructured":"Lee, B. K., Yun, Y. & Park, K. PLA micro- and nano-particles. Adv. Drug Deliv. Rev. 107, 176\u2013191 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"458_CR190","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1021\/acs.bioconjchem.8b00335","volume":"29","author":"C Onwukwe","year":"2018","unstructured":"Onwukwe, C. et al. Engineering intravenously administered nanoparticles to reduce infusion reaction and stop bleeding in a large animal model of trauma. Bioconjug. Chem. 29, 2436\u20132447 (2018).","journal-title":"Bioconjug. Chem."},{"key":"458_CR191","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/nbt1104-1335","volume":"22","author":"J Alper","year":"2004","unstructured":"Alper, J. US NCI launches nanotechnology plan. Nat. Biotechnol. 22, 1335\u20131336 (2004).","journal-title":"Nat. Biotechnol."},{"key":"458_CR192","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1039\/c2ib20117h","volume":"5","author":"RM Crist","year":"2013","unstructured":"Crist, R. M. et al. Common pitfalls in nanotechnology: lessons learned from NCI\u2019s nanotechnology characterization laboratory. Integr. Biol. 5, 66\u201373 (2013).","journal-title":"Integr. Biol."},{"key":"458_CR193","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2014.05.036","volume":"187","author":"CM Dawidczyk","year":"2014","unstructured":"Dawidczyk, C. M. et al. State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. J. Control. Release 187, 133\u2013144 (2014).","journal-title":"J. Control. Release"},{"key":"458_CR194","doi-asserted-by":"publisher","first-page":"eabj1577","DOI":"10.1126\/sciadv.abj1577","volume":"7","author":"A Yuk Simseok","year":"2021","unstructured":"Yuk Simseok, A. et al. Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis. Sci. Adv. 7, eabj1577 (2021).","journal-title":"Sci. Adv."},{"key":"458_CR195","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41579-020-00469-5","volume":"19","author":"W Gao","year":"2021","unstructured":"Gao, W. & Zhang, L. Nanomaterials arising amid antibiotic resistance. Nat. Rev. Microbiol. 19, 5\u20136 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"458_CR196","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3389\/fphar.2019.01153","volume":"10","author":"N-Y Lee","year":"2019","unstructured":"Lee, N.-Y., Ko, W.-C. & Hsueh, P.-R. Nanoparticles in the treatment of infections caused by multidrug-resistant organisms. Front. Pharmacol. 10, 1153 (2019).","journal-title":"Front. Pharmacol."},{"key":"458_CR197","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1021\/la047368k","volume":"21","author":"D Dendukuri","year":"2005","unstructured":"Dendukuri, D., Tsoi, K., Hatton, T. A. & Doyle, P. S. Controlled synthesis of nonspherical microparticles using microfluidics. Langmuir 21, 2113\u20132116 (2005).","journal-title":"Langmuir"},{"key":"458_CR198","doi-asserted-by":"publisher","first-page":"6580","DOI":"10.1002\/anie.201209145","volume":"52","author":"J Xu","year":"2013","unstructured":"Xu, J. et al. Future of the particle replication in nonwetting templates (PRINT) technology. Angew. Chem. Int. Ed. 52, 6580\u20136589 (2013).","journal-title":"Angew. Chem. Int. Ed."},{"key":"458_CR199","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jconrel.2021.07.028","volume":"337","author":"SN Tammam","year":"2021","unstructured":"Tammam, S. N. et al. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J. Control. Release 337, 258\u2013284 (2021).","journal-title":"J. Control. Release"},{"key":"458_CR200","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ejpb.2015.06.015","volume":"94","author":"R Mathaes","year":"2015","unstructured":"Mathaes, R., Winter, G., Siahaan, T. J., Besheer, A. & Engert, J. Influence of particle size, an elongated particle geometry, and adjuvants on dendritic cell activation. Eur. J. Pharm. Biopharm. 94, 542\u2013549 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"458_CR201","doi-asserted-by":"publisher","first-page":"15745","DOI":"10.1073\/pnas.1105200108","volume":"108","author":"CM Jewell","year":"2011","unstructured":"Jewell, C. M., Bustamante L\u00f3pez, S. C. & Irvine, D. J. In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc. Natl Acad. Sci. USA 108, 15745 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"458_CR202","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/ijms21031007","volume":"21","author":"C Sanchez-Cano","year":"2020","unstructured":"Sanchez-Cano, C. & Carril, M. Recent developments in the design of non-biofouling coatings for nanoparticles and surfaces. Int. J. Mol. Sci. 21, 1007 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"458_CR203","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"D Bobo","year":"2016","unstructured":"Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J. & Corrie, S. R. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm. Res. 33, 2373\u20132387 (2016).","journal-title":"Pharm. Res."},{"key":"458_CR204","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","volume":"81","author":"A Bernkop-Schn\u00fcrch","year":"2012","unstructured":"Bernkop-Schn\u00fcrch, A. & D\u00fcnnhaupt, S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 81, 463\u2013469 (2012).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"458_CR205","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5414\/CPP48138","volume":"48","author":"A Fisher","year":"2010","unstructured":"Fisher, A., Watling, M., Smith, A. & Knight, A. Pharmacokinetic comparisons of three nasal fentanyl formulations; pectin, chitosan and chitosan-poloxamer 188. Int. J. Clin. Pharmacol. Ther. 48, 138\u2013145 (2010).","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"458_CR206","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/molecules26020272","volume":"26","author":"J Jhaveri","year":"2021","unstructured":"Jhaveri, J., Raichura, Z., Khan, T., Momin, M. & Omri, A. Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics. Molecules 26, 272 (2021).","journal-title":"Molecules"},{"key":"458_CR207","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/1061186X.2015.1052074","volume":"23","author":"W Gao","year":"2015","unstructured":"Gao, W. & Zhang, L. Coating nanoparticles with cell membranes for targeted drug delivery. J. Drug Target. 23, 619\u2013626 (2015).","journal-title":"J. Drug Target."},{"key":"458_CR208","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4155\/tde-2017-0002","volume":"8","author":"TS de Almeida","year":"2017","unstructured":"de Almeida, T. S., J\u00falio, A., Mota, J. P., Rijo, P. & Reis, C. P. An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery. Ther. Deliv. 8, 461\u2013473 (2017).","journal-title":"Ther. Deliv."},{"key":"458_CR209","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1039\/C6MD00358C","volume":"7","author":"N Adawiyah","year":"2016","unstructured":"Adawiyah, N., Moniruzzaman, M., Hawatulaila, S. & Goto, M. Ionic liquids as a potential tool for drug delivery systems. MedChemComm 7, 1881\u20131897 (2016).","journal-title":"MedChemComm"},{"key":"458_CR210","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2010.05.019","volume":"148","author":"P Johansen","year":"2010","unstructured":"Johansen, P., Mohanan, D., Mart\u00ednez-G\u00f3mez, J. M., K\u00fcndig, T. M. & Gander, B. Lympho-geographical concepts in vaccine delivery. J. Control. Release 148, 56\u201362 (2010).","journal-title":"J. Control. Release"},{"key":"458_CR211","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"key":"458_CR212","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/nano10040787","volume":"10","author":"SY Fam","year":"2020","unstructured":"Fam, S. Y. et al. Stealth coating of nanoparticles in drug-delivery systems. Nanomaterials 10, 787 (2020).","journal-title":"Nanomaterials"},{"key":"458_CR213","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.smim.2017.09.011","volume":"34","author":"Y Liu","year":"2017","unstructured":"Liu, Y., Hardie, J., Zhang, X. & Rotello, V. M. Effects of engineered nanoparticles on the innate immune system. Semin. Immunol. 34, 25\u201332 (2017).","journal-title":"Semin. Immunol."},{"key":"458_CR214","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fbioe.2020.00166","volume":"8","author":"R Rampado","year":"2020","unstructured":"Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S. & Agostini, M. Recent advances in understanding the protein corona of nanoparticles and in the formulation of \u201cstealthy\u201d nanomaterials. Front. Bioeng. Biotechnol. 8, 166\u2013166 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"458_CR215","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.nano.2019.02.002","volume":"17","author":"AN Ilinskaya","year":"2019","unstructured":"Ilinskaya, A. N. et al. Nanoparticle physicochemical properties determine the activation of intracellular complement. Nanomedicine 17, 266\u2013275 (2019).","journal-title":"Nanomedicine"},{"key":"458_CR216","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/wnan.1339","volume":"7","author":"Q Yang","year":"2015","unstructured":"Yang, Q. & Lai, S. K. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7, 655\u2013677 (2015).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"458_CR217","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy, J. V. & Dickey, B. F. Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233\u20132247 (2010).","journal-title":"N. Engl. J. Med."},{"key":"458_CR218","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1097\/MIB.0000000000000117","volume":"20","author":"ME Johansson","year":"2014","unstructured":"Johansson, M. E. Mucus layers in inflammatory bowel disease. Inflamm. Bowel Dis. 20, 2124\u20132131 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"458_CR219","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai, S. K., Wang, Y.-Y. & Hanes, J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61, 158\u2013171 (2009).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"458_CR220","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","volume":"98","author":"K Netsomboon","year":"2016","unstructured":"Netsomboon, K. & Bernkop-Schn\u00fcrch, A. Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur. J. Pharm. Biopharm. 98, 76\u201389 (2016).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"458_CR221","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","volume":"11","author":"S Hua","year":"2015","unstructured":"Hua, S., Marks, E., Schneider, J. J. & Keely, S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine 11, 1117\u20131132 (2015).","journal-title":"Nanomedicine"},{"key":"458_CR222","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2217\/nnm-2016-0047","volume":"11","author":"K Maisel","year":"2016","unstructured":"Maisel, K. et al. Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo. Nanomedicine 11, 1337\u20131343 (2016).","journal-title":"Nanomedicine"},{"key":"458_CR223","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","volume":"124","author":"JT Huckaby","year":"2018","unstructured":"Huckaby, J. T. & Lai, S. K. PEGylation for enhancing nanoparticle diffusion in mucus. Adv. Drug Deliv. Rev. 124, 125\u2013139 (2018).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"458_CR224","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejpb.2015.01.008","volume":"97","author":"I Pereira de Sousa","year":"2015","unstructured":"Pereira de Sousa, I. et al. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Eur. J. Pharm. Biopharm. 97, 257\u2013264 (2015).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"458_CR225","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijpharm.2015.01.041","volume":"483","author":"S Bonengel","year":"2015","unstructured":"Bonengel, S., Pr\u00fcfert, F., Perera, G., Schauer, J. & Bernkop-Schn\u00fcrch, A. Polyethylene imine-6-phosphogluconic acid nanoparticles \u2014 a novel zeta potential changing system. Int. J. Pharm. 483, 19\u201325 (2015).","journal-title":"Int. J. Pharm."},{"key":"458_CR226","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17425247.2016.1114604","volume":"13","author":"J Youshia","year":"2016","unstructured":"Youshia, J. & Lamprecht, A. Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases. Expert Opin. Drug Deliv. 13, 281\u2013294 (2016).","journal-title":"Expert Opin. Drug Deliv."},{"key":"458_CR227","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/jpet.105.088146","volume":"315","author":"A Lamprecht","year":"2005","unstructured":"Lamprecht, A., Yamamoto, H., Takeuchi, H. & Kawashima, Y. Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. J. Pharmacol. Exp. Ther. 315, 196\u2013202 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"458_CR228","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/03639045.2010.523425","volume":"37","author":"PR Karn","year":"2011","unstructured":"Karn, P. R., Vani\u0107, Z., Pepi\u0107, I. & Skalko-Basnet, N. Mucoadhesive liposomal delivery systems: the choice of coating material. Drug Dev. Ind. Pharm. 37, 482\u2013488 (2011).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"458_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2008.12.013","volume":"72","author":"A Makhlof","year":"2009","unstructured":"Makhlof, A., Tozuka, Y. & Takeuchi, H. pH-sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model. Eur. J. Pharm. Biopharm. 72, 1\u20138 (2009).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"458_CR230","first-page":"4223","volume":"7","author":"V Mane","year":"2012","unstructured":"Mane, V. & Muro, S. Biodistribution and endocytosis of ICAM-1-targeting antibodies versus nanocarriers in the gastrointestinal tract in mice. Int. J. Nanomed. 7, 4223\u20134237 (2012).","journal-title":"Int. J. Nanomed."},{"key":"458_CR231","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.jaci.2019.04.012","volume":"143","author":"RD Huff","year":"2019","unstructured":"Huff, R. D., Carlsten, C. & Hirota, J. A. An update on immunologic mechanisms in the respiratory mucosa in response to air pollutants. J. Allergy Clin. Immunol. 143, 1989\u20132001 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"458_CR232","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner, J. R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799\u2013809 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR233","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ddtec.2005.05.006","volume":"2","author":"DN McLennan","year":"2005","unstructured":"McLennan, D. N., Porter, C. J. H. & Charman, S. A. Subcutaneous drug delivery and the role of the lymphatics. Drug Discov. Today Technol. 2, 89\u201396 (2005).","journal-title":"Drug Discov. Today Technol."},{"key":"458_CR234","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri2622","volume":"9","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Di Meglio, P., Qin, J.-Z. & Nickoloff, B. J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679\u2013691 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"458_CR235","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nri1670","volume":"5","author":"GJ Randolph","year":"2005","unstructured":"Randolph, G. J., Angeli, V. & Swartz, M. A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5, 617\u2013628 (2005).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Nature Reviews Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41578-022-00458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41578-022-00458-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41578-022-00458-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:25:52Z","timestamp":1733941552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41578-022-00458-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":235,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1038\/s41578-022-00458-5","relation":{},"ISSN":["2058-8437"],"issn-type":[{"value":"2058-8437","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"assertion":[{"value":"9 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.E.-A. serves as a consultant for Asalyxa Bio, working to develop \u2018Polymer Particle for Neutrophil Injury\u2019. O.E.-A. is listed as inventor on a recently filed patent application (US Provisional Application No. 62\/870,879). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}